FDA Inspection

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom CompoundingSeptember 5, 2025

FDA Inspection 1280796 - North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding - September 05, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding, with an inspection on September 5, 2025, issued by the Dallas District Office, covering human drugs.

Company: North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
Inspection Date: September 5, 2025
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · c27b65d6-4ba0-4c25-8c22-7de5cfd3de16

Violation Codes5

21 CFR 110.35(a)21 CFR 110.35(d)21 CFR 110.80(b)(2)21 CFR 110.93FD&C Act 501(a)(2)(A)

Full citation text and observation details available on the Dashboard.